Increasing in vitro fertilization success rate by turning embryo analysis from qualitative to quantitative

Project description

Embryo metabolism as a marker for IVF success

Millions of in vitro fertilisation (IVF) procedures are carried out every year, but clinical success is rather low. Selecting an embryo that will successfully implant and lead to a live birth has proved challenging. To address this problem, the EU-funded Embryospin project proposes to develop a novel method that assesses the embryo’s metabolic activity. The method is based on micro nuclear magnetic resonance (NMR), a miniaturised version of NMR instrumentation ideal for point-of-care medical diagnosis. Embryospin offers a novel biomarker for embryo vitality, which is expected to increase the chances of pregnancy, significantly reducing IVF cycles.

Fields of science

• medical and health sciences › clinical medicine › gynaecology › reproductive medicine
• medical and health sciences › clinical medicine › obstetrics
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › sensors
• medical and health sciences › clinical medicine › embryology

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

ANNAIDA TECHNOLOGIES SA

Net EU contribution

€ 1 611 687,00

Address

Avenue Louis-ruchonnet 26
1003 Lausanne
Switzerland

Region

Schweiz/Suisse/Svizzera › Région lémanique › Vaud

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 690 723,00